The Study
GLP-1 receptor agonists are associated with higher mitochondrial coupling efficiency in the human heart
This study found that people who were taking GLP-1 drugs had better heart muscle cell energy efficiency compared to similar people not taking the drug. But because it didn’t randomly assign people to the drug, we can’t say the drug caused the difference — it’s just a link, not proof.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
Doctors looked at tiny heart muscle samples from people who got a diabetes/weight drug (GLP-1-RA) and those who didn’t, to see if the drug helps heart cells make energy better.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 527 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This means the heart cells use energy more efficiently but don’t produce more total energy.
- 2It could help explain why these drugs protect the heart.
- 3The drug group had better heart cell energy efficiency (RCR: 2.43 vs 1.8), less energy leak (38 vs 58), and better membrane control (LCR: 0.39 vs 0.54).
- 4But their maximum energy power was the same (82 vs 97).
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
European Heart Journal
Year
2025
Authors
P. Gabert, S. Piel, N. Ophoff, J. Schmidt, D. Scheiber, R. Westenfeld, J. Szendroedi, M. Roden, M. Kelm, C. Granata, A. Polzin, E. Zweck
Related Content
Claims (4)
A diabetes drug made from Gila monster spit doesn't just help blood sugar — it can also help people lose weight, protect the heart, and even reduce cravings for things like alcohol or drugs.
Heart transplant patients on GLP-1 drugs might have healthier heart cell energy factories because their cells are leaking less energy.
Heart patients who got a new heart and take GLP-1 drugs (like those for diabetes) don’t seem to have any change in how well their heart muscle cells make energy — the drug doesn’t appear to affect this part of heart cell function.
People who've had heart transplants and take GLP-1 drugs might have healthier heart cell energy factories, because their cells use energy more efficiently and waste less fuel.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.